Researchers say online health information could be misleading
While many patients use the Internet to search for health information, some websites can contain inadequate or inaccurate information, according […]
While many patients use the Internet to search for health information, some websites can contain inadequate or inaccurate information, according […]
Country: Uganda Sponsoring Organisation and Partners: Celtel, AIDs Information Centre (AIC), Merck, and the Dutch Ministry of Foreign Affairs A […]
Biomedical research in India has received a shot in the arm with the Wellcome Trust, Britain’s largest health charity, entering into an agreement with the Indian government’s biotechnology department to fund cutting-edge research.
Pharmaceutical and Biotechnology major Wockhardt Limited today announced its first quarter results (April
A Summit on the Nascent Domain of Behavioural TelehealthThe inaugural summit on Behavioral Telehealth: Technology for Behavior Change & Disease […]
Indegene Lifesystems Pvt Ltd., a scientific partner to global pharmaceutical and life sciences companies, today highlighted the benefits its pharmaceutical clients are reaping through comprehensive and multichannel patient support and adherence programs.
Prometheus Laboratories Inc, a specialty pharmaceutical and diagnostic company, announced that it has entered into a definitive agreement to be acquired by Nestl
Indegene Lifesystems Pvt Ltd, a scientific partner to global pharmaceutical and life sciences companies, today announced that it has won seven awards at the prestigious Hermes Creative Awards 2011.
Pharma RFID market expected to hit US$ 1 trillion by 2020 The market for Radio Frequency Identification (RFID) applications in […]
Recent analysis shows that the high priced research and development companies which show $1.3 billion cost are not real.
The FCCB holders, funded by QVT, Sun Pharma and Syndicate Bank, hold bonds worth $42 million in a pharmaceutical company Wockhardt Ltd.
The industry department is about to finalise the terms under which the government can order the manufacture of drugs without seeking the permission of the patent holder by the end of this month.
Pfizer loses $10-billion-a-year revenue in November this year as its major cholesterol drug Lipitor patent expires.